http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-48133-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0096 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 |
| filingDate | 1979-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1984-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-48133-B1 |
| titleOfInvention | A sold stable pharmaceutical composition based on 17 -ethynyl-1,3-dibenzoyloxy-7 -methyl-1,3,5(10)-oestratien-17 -ol |
| abstract | 1,3-Dibenzoic acid esters of 17 alpha -ethynyl-7 alpha -methyl-1,3,5(10)-estratriene-1,3,17 beta -triol possess strong estrogenic and ovulation-inhibiting activities. As compared to the corresponding diacetic acid ester, these dibenzoic acid esters remain stable over 2-7 months even in the desired, low dosage at a thermal load of up to 60 DEG C.[EP0004898A1] |
| priorityDate | 1978-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506267 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109 |
Total number of triples: 13.